Hilgert, Elien
Van Neste, Christophe
Bekaert, Sarah-Lee
Martens, Fien
Vanhauwaert, Suzanne
Sanders, Ellen
Verstraelen, Peter
Risseeuw, Martijn
Westerhout, Ellen M.
Grannetia, Mark A.
Van Calenbergh, Serge
Van Roy, Nadine
De Vos, Winnok H.
Wolthuis, Rob W. F.
Speleman, Frank
Depestel, Lisa
Durinck, Kaat
Funding for this research was provided by:
Fonds Wetenschappelijk Onderzoek (11C3921N)
Fonds Wetenschappelijk Onderzoek (12N6917N)
Fonds Wetenschappelijk Onderzoek (12U4718N)
Fonds Wetenschappelijk Onderzoek (I003420N)
Fonds Wetenschappelijk Onderzoek (G087221N)
Fonds Wetenschappelijk Onderzoek (G087221N)
Stichting Villa Joep (N°33 “Tailored Combination Therapies to Target the Multiple Faces of Neuroblastoma")
Stichting Villa Joep (N°33 “Tailored Combination Therapies to Target the Multiple Faces of Neuroblastoma")
Stichting Villa Joep (N°23: “Identification and functional analysis of replicative stress resistors as novel therapeutic targets in neuroblastoma)
Stichting Villa Joep (N°23: “Identification and functional analysis of replicative stress resistors as novel therapeutic targets in neuroblastoma")
Antwerp University Special Research Fund (BOF N°52006)
Ghent University Special Research Fund (BOF.GOA.2022.0003.03)
Ghent University Special Research Fund (BOF.GOA.2022.0003.03)
Article History
Received: 31 May 2025
Accepted: 20 November 2025
First Online: 27 November 2025
Competing interests
: The authors declare no competing interests.